Introduction {#Sec1}
============

Since the chance observation of a dog with acute unilateral vestibulopathy who demonstrated less imbalance during running than during walking^[@CR1]^, the interactions of gait velocity, imbalance and vestibular symptoms in people with vestibulopathy have become a topic of great interest. Inspired by the observation in the dog, Brandt, *et al*.^[@CR1]^ demonstrated with a simple setup that humans with acute unilateral vestibulopathy could run with less deviation to the affected side than while walking. Since then, reductions in temporal gait variability and reductions in stride length variability in bilateral vestibulopathy (BVP) during faster, compared to slower walking have been observed^[@CR2]--[@CR4]^. BVP, a severe bilateral reduction of vestibular function that results in severe balance deficits and an increased fall risk^[@CR5]--[@CR10]^, was recently defined by the Bárány Society^[@CR11]^. Interestingly, the same studies revealed that patients with BVP do not self-select walking speeds that minimize temporal or spatial gait variability^[@CR2]--[@CR4]^, suggesting that these are not the only source of instability or inefficiency with which people with BVP must cope. However, further research into the relationships between vestibulopathy, walking speed and gait variability is needed to confirm and expand on these previous findings, as these three previous studies had some potential drawbacks, namely a limited number of gait parameters being analysed^[@CR2]^, too few strides^[@CR12]--[@CR15]^ for a robust analysis of gait variability^[@CR2],[@CR3]^, the use of only preferred walking speeds or percentages of preferred walking speeds (ecologically valid, but less control over influencing factors)^[@CR2]--[@CR4]^, small sample size^[@CR4]^, lack of a healthy control group^[@CR3],[@CR4]^ and the presence of sham vestibular stimulation in the control condition^[@CR4]^. The study of balance and gait deficits in BVP is both important for improving clinical care and for objective quantification of the effects of novel interventions, such as vestibular implants^[@CR16],[@CR17]^. Furthermore, it is fundamental to our understanding of the vestibular contributions to gait and balance control.

The sensory contributions to gait appear to depend on walking speed, which may partly explain the above described findings and will affect walking speed selection in people with vestibulopathy. Visual perturbations such as distorting prisms or closed eyes have reducing impact on most gait variability parameters as one walks faster^[@CR18],[@CR19]^ with the exception of step width variability, which appears to increase with visual perturbation at faster walking speeds^[@CR19]^. Similarly, vestibular perturbations via galvanic vestibular stimulation have less impact on gait direction and variability at higher speeds^[@CR20],[@CR21]^. Additionally, the vestibular influence on lower limb muscles (determined by examining vestibulo-muscular coupling via lower limb muscle electromyography during vestibular stimulation) is selectively suppressed with increased cadence and speed during walking^[@CR22],[@CR23]^, purported to be related to a shift in the control mechanisms of mediolateral stability with increasing walking speeds from active stabilization at the lower limb joints during the stance phase to foot placement^[@CR22],[@CR24]^. Despite selective suppression of the vestibular influence on some lower limb muscles at faster walking speeds, significant increases in frontal spatial variability with increasing walking speeds have been reported in BVP^[@CR4]^, suggesting that vestibular information remains important for mediolateral stability during gait at faster speeds.

To further investigate the walking speed dependency of gait variability in vestibulopathy, we analyzed the gait of people with BVP and of healthy control participants. We aimed to determine the effects of systematic increases in walking speed on spatiotemporal gait parameters and their variability in these participant groups. Secondly, we aimed to assess if these parameters would differentiate between healthy participants, and participants with BVP who could and could not complete all of the planned walking speed trials. We hypothesized that, for all participants, step and double support time and step length variability would systematically reduce with increases in walking speed, whereas step width variability would systematically increase, in agreement with previous work^[@CR2]--[@CR4]^. We further postulated that, based on earlier studies and despite their limitations described above^[@CR2],[@CR3]^, step and double support time and step length variability at slower walking speeds would be most distinguishing between the healthy control participants and patients with BVP, and also between the patients with BVP that could completely and only partly complete the measurement protocol, whereas step width variability would be most distinguishing at faster walking speeds, based on one study showing an increase in BVP^[@CR4]^. Additionally, we conducted an explorative analysis in the patient groups examining correlations between the outcomes of the most distinguishing gait parameters identified and clinical vestibular tests conducted as part of a larger clinical study (video head impulse test \[vHIT\], ocular and cervical vestibular evoked myogenic potentials \[oVEMP and cVEMP\] and dynamic visual acuity \[DVA\]) that are indicative of vestibular functional integrity and commonly used in clinical settings, with the aim to explore if these tests could give an indication about gait-related function in BVP.

Methods {#Sec2}
=======

Participants {#Sec3}
------------

Forty-four people with BVP participated in this study (22 males, 22 females; age: 57.6 ± 11.5 years, age range: 21 to 74; height: 174.5 ± 9.7 cm; weight: 80.4 ± 17 kg). Inclusion criteria were a prior diagnosis of bilateral vestibular hypofunction at the Maastricht University Medical Centre+ (imbalance and/or oscillopsia during locomotion and summated slow phase mean peak velocity of the nystagmus of less than 20°/s during bithermal caloric tests) and the self-reported ability to walk independently without assistance. Please note that this study began prior to the publication of the Bárány Society guidelines^[@CR11]^, which are slightly different. Potential participants were not included if they were unable or unwilling to stop taking anxiety or depression medication for the week before the measurements. In addition, two healthy control groups comprised of 12 healthy younger adults (Young; 5 males, 7 females; 25.1 ± 2.8 years; 174.9 ± 7.3 cm; 72.6 ± 13.5 kg) and 12 healthy older adults (Older; 8 males, 4 females; 71.5 ± 4.8 years; 171.5 ± 9.1 cm; 79.5 ± 11.8 kg) with no history of balance or gait difficulties and no history of dizziness participated in this study. These specific groups were included to account for the age range in the BVP group and to provide an estimation of the effect of ageing alone on the outcome parameters. The study was explained before obtaining written informed consent, was conducted in accordance with the Declaration of Helsinki and was approved by the Maastricht University Medical Centre medical ethics committee (gait measurements: NL58205.068.16; vestibular tests: NL52768.068.15).

Gait analysis setup, data processing and procedure {#Sec4}
--------------------------------------------------

The gait measurements were conducted using the Computer Assisted Rehabilitation Environment Extended (CAREN; Motekforce Link, Amsterdam, The Netherlands), which includes a dual-belt force plate-instrumented treadmill (Motekforce Link, Amsterdam, The Netherlands; 1000 Hz), a 12 camera motion capture system (100 Hz; Vicon Motion Systems, Oxford, UK) and a virtual environment (city-style street with passing objects and structures) projected onto a 180 degrees curved screen (note that our intention was to provide optic flow for all participants, but after the first few measurements with the BVP group, it became clear that optic flow should be turned off for this group to prevent dizziness and nausea. The implications for this on the results are discussed in the limitations section). For all measurement sessions, a safety harness connected to an overhead frame was used. At the request of some of the participants with BVP, a handrail was also positioned on the treadmill, the use of which was monitored and recorded. Six retroreflective markers were attached to anatomical landmarks (C7, sacrum, left and right trochanter and left and right hallux) and were tracked by the motion capture system. Marker tracks were filtered using a low pass second order Butterworth filter (zero-phase) with a 12 Hz cut-off frequency. Foot touchdown was determined using combined force plate (50 N threshold) and foot marker data^[@CR25]^. This combined method was used to be able to accurately account for foot touchdowns and toe-offs occurring in the center of the treadmill triggering both force plates simultaneously. For these steps, the foot marker method was used and then corrected based on the average discrepancy between the force plate method and the marker method timing for all steps that contacted only one force plate. The spatiotemporal gait parameters of interest were step length (anteroposterior distance between the hallux markers at foot touchdown), step time (time from touchdown of one foot to touchdown of the next foot), step width (mediolateral distance between the hallux markers at foot touchdown) and double support time (time spent with both feet on the ground). Means, standard deviations and coefficients of variation (CV) were determined for each speed for each participant.

Each session began with walking familiarization trials at 0.4 m/s up to 1.6 m/s in 0.2 m/s increments. At least 60 s were used for each speed, and further time was provided to familiarize to each speed if deemed necessary by either the participant, the CAREN operator or the research clinician. At the end of each speed trial, the decision to continue to the next (faster) speed was made in a similar manner. If the participant was not comfortable progressing to the next speed or if the CAREN operator or research clinician did not think it was safe or feasible to progress, then the participant continued at the current speed instead. Participants were then given sufficient rest before continuing with the measurements. Single two-to-three-minute-long measurements (to ensure a minimum of 60 strides per speed) were then conducted at each prescribed speed that was completed during familiarization. Multiple set walking speeds were used as opposed to the majority of previous studies which have used either percentages of preferred walking speeds or self-perceived slow, normal and fast walking speeds, in order to have more control over the walking speed condition.

Clinical vestibular function tests setup and procedures {#Sec5}
-------------------------------------------------------

Following a sufficient rest period that was determined on an individual basis, the BVP group proceeded with the clinical vestibular testing battery. Between each test, sufficient rest was provided based on feedback from the patient and the judgement of the clinical researcher. The vHIT was performed with the EyeSeeCam system (EyeSeeCam VOG; Munich, Germany) and the ICS Impulse system (GN Otometrics A/S, Denmark) to test semicircular canal function and determine the gain of the vestibulo-ocular reflex (VOR). Both systems measured the movement of the right eye. The distance of the back of the static chair was 2 meters to the point of fixation. The point of fixation consisted of a green dot on the wall, produced by a laser on a tripod. If necessary, adhesive plasters were used to lift the upper eyelid a little to secure the visibility of the pupil for the camera in all directions. Goggle movement was minimized by adjusting the strap of the goggles to every subject. The vHIT system was calibrated according to the protocol of the system. After calibration, the subject was instructed to not touch their head including the goggles. The examiner stood behind the participant with two hands firmly on top of the participant's head without touching the strap of the goggles. The examiner then applied head impulses in six different movements to test each canal^[@CR26]^. The horizontal head impulses comprised a peak velocity of \>150°/s and the vertical head impulses a peak head velocity of \>100°/s. The amplitude of the movements was 10--20°. Only outward impulses were used^[@CR27]^. The vHIT was defined as abnormal if the VOR gain was below 0,7 and/or if covert saccades were observed in 50% or more of the traces^[@CR26],[@CR28]^.

DVA, which is used to assess gaze stabilization via the VOR during gait-related head movements, was assessed on a regular treadmill (1210 model, SportsArt, Inc., Tainan, Taiwan, China.) with the participant positioned 2.8 meters from a computer screen. Firstly, the static visual acuity was determined during stance, followed by the assessment of the DVA during walking at 2, 4 and 6 km/h. One letter at a time was randomly displayed on the screen from a chart of Sloan letters (CDHKNORSVZ)^[@CR29]^. Starting at a logMAR (log of the Minimum Angle of Resolution^[@CR30]^); of 1.0, five random letters were shown at each logMAR (decreasing in steps of 0.1 logMAR). When four out of five letters were correctly identified, the corresponding logMAR was considered achieved. The outcome of the DVA was the difference between the static logMAR and the logMAR for each of the three walking speeds. The result was omitted if the subject needed a handrail to walk at that speed or if it wasn't possible to walk at that speed at all^[@CR31]^.

cVEMP and oVEMP were assessed with the Neuro-Audio system (v2010, Neurosoft, Ivanovo, Russia) in order to determine the function of the otolith organs (saccule and utricle, respectively) and their corresponding nerves. A monaural stimulation with in-ear earphones was used with air conduction tone bursts at 500 Hz and a stimulation rate of 13 Hz using a blackman window function with a two-cycle rise/fall and no plateau phase. Tone bursts of maximum 130 dB sound pressure level (SPL) were used. A stepwise approach was used to determine the threshold with a precision of 5 dB SPL^[@CR32]^. Positive (P1) and negative (N1) peaks in the recorded biphasic waveform were marked for both cVEMPs and oVEMPs. The thresholds were determined as the lowest stimulus intensities to elicit recognizable peaks. If it wasn't possible to find a VEMP response, it was defined as a threshold of \>130 dB SPL. For the cVEMP, the participant was positioned lying down with the back positioned at a 30° angle above the horizontal plane and was asked to turn their head towards the non-measured side and lift their head during the measurement. The cVEMP was recorded at the ipsilateral sternocleidomastoid muscle. Two electrodes were placed on the sternocleidomastoid muscles, the reference electrode on the sternum, and the earth electrode on the forehead. Electrode impedances of 5 kΩ or lower were accepted and otherwise the electrode was replaced. To ensure correct muscle contraction, a feedback system using a screen was provided. An average of 200 EMG traces with a minimum mean rectified voltage (MRV) of 65µV and a maximum MRV of 205µV was accepted^[@CR33],[@CR34]^. The oVEMP was recorded at the contralateral inferior oblique muscle. Five electrodes were used: the recording electrodes beneath the eyelid, just lateral of the pupil when gazing forward and centrally, the reference electrodes beneath the recording electrode and the earth electrode on the forehead. The participant was asked to keep their gaze at a focus point placed at a 30 degrees angle behind the head. An average of at least 300 EMG traces was accepted^[@CR35]--[@CR37]^.

Statistics {#Sec6}
----------

From the 44 participants with BVP that started the study, 38 participants were able to complete at least the three slowest walking speeds without assistance (group hereafter referred to as BVP) and these participants' data were taken for the comparison with the healthy groups. For the within BVP comparisons, three groups were formed. One group was able to complete all of the gait measurements without assistance (BVP All Gait; n = 26), the second was only able to complete some of the speeds without assistance (BVP Part Gait; n = 12; all of this group were able to complete the measurements at least up to 0.8 m/s) and the final group (BVP No Gait; n = 6) did not start the recorded gait trials (see "Results" for details on this group).

To investigate the walking speed effects on gait and this effect's potential interaction with vestibular function, mixed-effects models using the restricted maximum likelihood method with the fixed effects walking speed, participant group, and speed by group interaction were conducted for the means and CVs of step time and length, step width and double support time. To further investigate the potential of gait variability to distinguish between BVP groups, mixed-effects models as described above were applied with groups BVP All Gait and BVP Part Gait to the CV of all four gait parameters across all speeds that included data points from each group. Bonferroni post hoc comparisons were performed to assess the group differences within speeds for each of the gait parameters.

The vHIT testing revealed abnormal canal function in all or most directions for almost all of the participants with BVP (i.e. exceptions were two participants with BVP who had only one abnormal result out of six). As almost all outcomes were abnormal and there was no possibility to distinguish between groups, analysis of the vHIT results in relation to gait was not taken further. For all completed DVA trials with a logMAR change value during the three walking speeds compared to standing and when oVEMP or cVEMP thresholds were detected, these values were grouped and Pearson correlations with the gait parameters that showed highest variability and/or distinguished between BVP groups were conducted (see Results). Age, height, weight and body mass index (BMI) were compared across the participant groups BVP, Young and Older, and within the three BVP groups (BVP All Gait, BVP Part Gait, BVP No Gait) using one-way ANOVAs with Bonferroni corrections for multiple comparisons.

Results {#Sec7}
=======

Twenty-six participants with BVP were able to complete all of the gait measurements without assistance (BVP All Gait). Twelve participants with BVP were only able to complete some of the speeds (BVP Part Gait), of which one participant stopped after 0.8 m/s, one after 1.0 m/s, four after 1.2 m/s and six after 1.4 m/s. Six participants with BVP were assigned to the BVP No Gait group for the following reasons: one participant became dizzy and nauseated during familiarization and could not continue; three participants were not able to walk during familiarization without handrail support; two participants found treadmill walking too challenging and could not continue. The demographic data of these three groups, as well as the healthy control group can be found in Table [1](#Tab1){ref-type="table"}. The one-way ANOVAs revealed a significant group effect (BVP, Young, Older) for age (F (2,59) = 88), P \< 0.0001), with age significantly differing between each of the groups (P \< 0.0001). Height, weight and BMI did not significantly differ across these groups. No significant differences in demographics were found with the three BVP groups.Table 1Participant Group Characteristics.nAge (y)Height (cm)Weight (kg)Body Mass IndexYoung12 (7 female)25.1 ± 2.8\*174.9 ± 7.372.6 ± 13.523.6 ± 2.8Older12 (4 female)71.5 ± 4.8\*171.5 ± 9.179.5 ± 11.826.9 ± 2.2BVP38 (20 female)56.1 ± 11\*174.6 ± 10.180.2 ± 17.626.1 ± 4.2   *BVP All Gait*26 (10 female)55.1 ± 11.4176.8 ± 9.980.3 ± 17.825.4 ± 3.8   *BVP Part Gait*12 (10 female)59.2 ± 9169.7 ± 979.9 ± 1827.6 ± 4.7   *BVP No Gait*6 (2 female)65.3 ± 13.6174 ± 6.982.4 ± 13.427.2 ± 3.8Values are means ± SD. \*Significantly different from each other (*P* \< 0.0001).

The mixed-effects models with walking speed (0.4 to 1.6 m/s) and group (BVP, Young, Older) as factors revealed significant walking speed effects for the means and CV of step time and length, step width and double support time (*P* ≤ 0.0003), significant group effects for all parameters except step width means (*P* ≤ 0.0151) and significant walking speed by group interactions for the means of step time, double support time and step width (*P* ≤ 0.0053) and the CV of step width (*P* \< 0.0001). The mixed-effects model results and summary of the between group Bonferroni comparisons are displayed in Fig. [1](#Fig1){ref-type="fig"} (means) and Fig. [2](#Fig2){ref-type="fig"} (CVs), and the full Bonferroni comparison results are available in Supplementary Tables [1](#MOESM1){ref-type="media"} and [2](#MOESM1){ref-type="media"}.Figure 1Boxplots of the median, interquartile range and 5^th^ and 95^th^ percentile of the means of step time, step length, double support time and step width across all conducted walking speeds in BVP, Young and Older participant groups. The black horizontal lines indicate significant between group differences for the indicated speed (P \< 0.05, Bonferroni adjusted).Figure 2Boxplots of the median, interquartile range and 5^th^ and 95^th^ percentile of the coefficients of variation (CV) of step time, step length, double support time and step width across all conducted walking speeds in BVP, Young and Older participant groups. The black horizontal lines indicate significant between group differences for the indicated speed (P \< 0.05, Bonferroni adjusted).

The mixed-effects models with walking speed (0.4 to 1.4 m/s) and group (BVP All Gait and BVP Part Gait) as factors revealed significant walking speed effects for the CV of all parameters (*P* \< 0.0001). Significant group effects were found for the CV of step time, step length and double support time (*P* ≤ 0.0162) and a significant walking speed by group interaction was found for the CV of double support time (*P* = 0.0172). The mixed-effects model results and summary of the between group Bonferroni comparisons are displayed in Fig. [3](#Fig3){ref-type="fig"} and the full Bonferroni comparison results are available in Supplementary Table [3](#MOESM1){ref-type="media"}.Figure 3Boxplots of the median, interquartile range and 5^th^ and 95^th^ percentile of the coefficients of variation (CV) of step time, step length, double support time and step width across all walking speeds with data from participant groups BVP All Gait and BVP Part Gait. The black horizontal lines indicate significant between group differences for the indicated speed (P \< 0.05, Bonferroni adjusted).

When cVEMP and oVEMP thresholds were detected, and when a speed of the DVA was completed, these values were taken and Pearson correlations were conducted with the CVs of step time, step length and double support time at 0.4 m/s and the CV of step width at 1.6 m/s, being the speeds with the highest variability in those parameters from the previous analysis. These results can be seen in Table [2](#Tab2){ref-type="table"}. Only two significant correlation of 28 were found (change in logMAR scores during the DVA with Double Support CV at 6 km/h and oVEMP Left and Step Length CV at 0.4 m/s; Table [2](#Tab2){ref-type="table"}).Table 2Pearson correlations between the cVEMP and oVEMP thresholds, the change in logMAR scores during each of the three DVA walking speeds and the gait parameters.Step Time CV 0.4 m/sStep Length CV 0.4 m/sDouble Support Time CV 0.4 m/sStep Width CV 1.6 m/scVEMPRightr0.089870.32590.2576−0.350195% CI−0.3935 to 0.5343−0.1662 to 0.6881−0.2379 to 0.6467−0.7554 to 0.2489P (two-tailed)0.72290.18680.3020.241n18181813cVEMPLeftr−0.24250.1195−0.1732−0.504395% CI−0.659 to 0.2878−0.3999 to 0.5808−0.616 to 0.3528−0.8362 to 0.09795P (two-tailed)0.36550.65950.52120.0945n16161612oVEMPRightr0.46530.5610.2860.464995% CI−0.7074 to 0.9554−0.6361 to 0.9654−0.7975 to 0.9329−0.7076 to 0.9553P (two-tailed)0.42970.32510.64080.4301n5555oVEMPLeftr−0.049950.79140.08001−0.360595% CI−0.6911 to 0.63520.2684 to 0.9541−0.6169 to 0.7066−0.8494 to 0.4614P (two-tailed)0.8985**0.0111**0.83790.3803n9998DVA2 km/hr−0.12440.01669−0.2151−0.0962395% CI−0.4271 to 0.2034−0.3046 to 0.3346−0.5004 to 0.1123−0.4662 to 0.3024P (two-tailed)0.45680.92080.19470.6401n38383826DVA4 km/hr0.06088−0.17110.034130.242295% CI−0.2639 to 0.3733−0.4654 to 0.1572−0.2887 to 0.35−0.1602 to 0.5756P (two-tailed)0.71660.30430.83880.2332n38383826DVA6 km/hr−0.3145−0.3199−0.4338−0.0612995% CI−0.6371 to 0.1018−0.6406 to 0.09588−0.7125 to −0.0369−0.4803 to 0.3805P (two-tailed)0.13450.1275**0.0342**0.7918n24242421

Post-hoc analysis of gait data based on VEMP results {#Sec8}
----------------------------------------------------

In order to further investigate differences within the patient group, we conducted an analysis of the gait data of the participants with and without at least one detected VEMP threshold for the same four parameters as the correlations: the CVs of step time, step length and double support time at 0.4 m/s and the CV of step width at 1.6 m/s. Given that all of the participants with no VEMP threshold detected also had abnormal outcomes on the vHIT for most or all of the six directions tested, the purpose of this analysis was to compare the gait of participants with and without detectable canal and otolith function. Independent samples t-tests with Welch's corrections did not reveal any significant differences between the participants with and without at least one detectable VEMP threshold (0.0965 \< P \< 0.746).

Discussion {#Sec9}
==========

We aimed to determine the effects of systematic increases in walking speed on spatiotemporal gait parameters and their variability in people with BVP. We investigated if these parameters would distinguish between healthy participants and participants with BVP, and between patients with BVP who could and could not complete all of the planned walking speed trials (a simple proxy of locomotor capacity). Our hypothesis, that step and double support time and step length variability would systematically reduce with increases in walking speed, whereas step width variability would systematically increase, was confirmed as significant walking speed effects were found for all gait variability parameters. We additionally hypothesized that step and double support time and step length variability at slower walking speeds would be most distinguishing between the healthy control participants and patients with BVP, and also between the patients with BVP that could completely and only partially complete the measurement protocol, whereas step width variability would be most distinguishing between these groups at faster walking speeds. This hypothesis was partly confirmed; step length CV differed between groups BVP and Young and between groups BVP All Gait and BVP Part Gait, double support time CV differed between groups BVP and Young and step width CV differed between groups BVP and Young and BVP and Older for step width variability, but other parameters did not significantly differ at the pairwise comparison level, despite the group effects found for all parameters except step width CV in the BVP All Gait vs. BVP Part Gait analysis.

Regarding our explorative analysis in the patient groups examining correlations between the outcomes of four clinical vestibular tests (vHIT, oVEMP, cVEMP, DVA) and the most distinguishing gait parameters identified, only one significant correlation between the change in logMAR scores during the DVA and the gait parameters were found (6 km/h and Double Support CV; Table [2](#Tab2){ref-type="table"}). One significant correlation of 16 was found between the VEMP thresholds and the gait parameters, but only nine pairs of data were included in this test and if a Bonferroni correction is made for the p values of these 16 tests, it is no longer significant (oVEMP Left and Step Length CV at 0.4 m/s; Table [2](#Tab2){ref-type="table"}). Similarly, the one significant correlation between a DVA parameter and gait variability (DVA 6 km/h and Double support time CV 0.4 m/s) does not meet the significance threshold if a Bonferroni correction for the 12 tests is made. Even though this study clearly demonstrates the significant contribution of vestibular function to gait, our exploratory analysis confirms the complex contribution of vestibular information during every-day activities and the difficulty in translating current objective clinical measures to highly relevant patient symptoms.

Determining meaningful and distinguishing gait parameters in BVP is vital for the development of interventions, as is using tasks that sufficiently replicate the day-to-day challenges of these patients, to determine candidates for intervention and to assess the effect of those interventions. Two promising interventions currently under development and investigation include noisy galvanic vestibular stimulation (nGVS) and vestibular implants^[@CR16],[@CR17],[@CR38]--[@CR40]^. Discussions of these treatment options can be found elsewhere^[@CR16],[@CR38]^, but it is important to note that both show early signs of utility for improving gait in BVP^[@CR4],[@CR41]^. However, it remains to be seen if improvement due to nGVS or a vestibular implant in steady state gait would likewise be seen in more dynamic locomotor task performance, where even unilateral vestibulopathy leads to significantly poorer stability performance^[@CR42]^. It should be noted that while this study examined spatiotemporal variability, differences in dynamic gait stability were not directly assessed and the two are not necessarily equivalent^[@CR43]--[@CR45]^. The parameters presented here represent the amount of variability in the gait parameters, but do not necessarily indicate the overall stability of the participants. Therefore, future work should investigate how dynamic gait stability is altered in BVP and how this is affected by changes in walking speed. Additionally, we suggest that quantification of vestibulospinal reflexes and reflex gains associated with gait stability control in BVP should be conducted, in order to better understand the underlying mechanisms of changes in gait stability in vestibulopathy.

The current study confirmed previous findings of reductions in temporal gait variability and reductions in sagittal plane spatial gait variability in vestibulopathy during faster, compared to slower walking^[@CR2]--[@CR4]^. We extend these previous findings as the current study employed fixed (not self-selected) speeds that were systematically increased, with 120 steps analyzed per speed, thereby improving the reliability of the outcomes. Our findings also align with the growing body of literature indicating a shift from sensory feedback-driven balance control to an increasingly feedforward control with increasing locomotor speed^[@CR1],[@CR18],[@CR22],[@CR23],[@CR46]^, but suggest that this may not apply, at least not to the same extent, for mediolateral balance control during gait which may continue to require active control of foot placement in the mediolateral plane. Importantly, the current results further the previous findings by additionally showing that these parameters are related to the locomotor capacities of people with BVP.

We confirmed previously reported increases in step width variability with increasing walking speeds in people with BVP^[@CR4]^. Previous studies have shown that vestibular perturbations have less impact on direction and variability at higher walking speeds^[@CR20],[@CR21]^ and that the vestibular influence on lower limb muscles is selectively suppressed with increased cadence and speed during walking^[@CR22],[@CR23]^. However, the current step width variability results, combined with those of Wuehr, *et al*.^[@CR4]^ suggest that vestibular information remains important for mediolateral foot placement at increased walking speeds. During the swing phase when foot placement is coordinated and determined, there is reduced proprioceptive input due to only one foot being in contact with the ground. Therefore, we could reason that vestibular input becomes more important in this phase, and disturbed or lacking vestibular input may decrease foot placement accuracy. These results also provide some explanation as to why people with BVP do not self-select walking speeds that minimize temporal or sagittal plane spatial gait variability^[@CR2]--[@CR4]^. Dramatic increases in step width variability may be undesirable due to reduced stability control or increased energetic costs of mediolateral stabilization^[@CR47]--[@CR49]^. Based on the current results, either reason is plausible, as some participants in the BVP Part Gait group did not continue to the faster speeds due to instability, while others could not continue due to being unable to keep up with the speed of the treadmill (implying an energetic or physiological limitation, not a stability-related one). The vestibular influence on gait economy has not yet been thoroughly investigated.

The healthy control groups in this study were not directly age matched with the BVP group, but rather represent healthy participants at the younger and older end of the age range of the BVP group. Variability in step time, double support time and step length of the older group tended to fall between that of the younger and BVP group, showing few statistical differences to either (probably due to a lack of statistical power at the pairwise comparison level). The boxplots seem to indicate that the group Older tend towards the results of group Young for double support time and step length variability. In order to further investigate this issue, we calculated the Cohen's d effect sizes for each group comparison (Young vs. Older, Young vs. BVP and Older vs. BVP) and averaged these across the walking speeds for Step Time CV (0.65, 0.98, 0.39), Step Length CV (0.95, 1.31, 0.60), Double Support Time CV (0.58, 1.00, 0.50) and Step Width CV (0.21, 1.04, 0.84). These effect sizes confirm that the largest differences were always between the Young and BVP groups, but that the differences between the Older and BVP groups were also always moderate to large, even if not statistically significant, indicating that while age may have been a factor in the Young-BVP comparisons, it certainly does not explain the differences found. However, the group difference in step width variability appear to be more robust, with large significant differences between the BVP group and each healthy group, and no difference due to healthy ageing alone, in agreement with previous studies^[@CR50],[@CR51]^. However, other limitations should be kept in mind. Firstly, we did not perform any tests of somatosensory function in the older adult group, and while we think our inclusions criteria "no history of balance or gait difficulties and no history of dizziness" probably deemed somatosensory dysfunction unlikely, it cannot be entirely ruled out. We did however perform the DVA and vHIT tests with nine and eight out of 12 older participants, respectively, which revealed normal function (due to equipment issues, the remaining older adults were not assessed on these tests). Regarding the gait results, we caution comparing the CV of step width to studies of overground walking, as it has been shown in healthy participants that walking on the CAREN results in increased step width variability compared to overground walking^[@CR52]^. Additionally, the use of a safety harness may result in small differences to unconstrained overground gait^[@CR53]^. Furthermore, treadmill walking appears to be more challenging for people with BVP, evidenced by the fact that the BVP No Gait group were not able to successfully complete the familiarization period, despite reporting being able to walk independently without assistance. We would therefore caution a direct comparison of treadmill-derived gait results with overground gait results in BVP. It should also be noted that the walking speeds used in the current study were not randomized, but progressed from slow to fast, and this could have led to an order effect. We hope that this was minimized by our familiarization protocol, but it cannot be ruled out. This should not have affected our comparisons, however, as all participants followed the same protocol. Minor fatigue may have occurred during the assessments, but this should have been minimized as the participants were monitored and breaks were provided when necessary. Regarding the fact that the healthy groups walked with optic flow and the BVP group walked with the virtual environment fixed (so as to provide the same lighting), we do not expect that this difference would have altered our results, as two previous studies found no, or negligible, differences in the parameters assessed here between fixed speed walking with and without virtual reality^[@CR54],[@CR55]^. The only previous study that did find differences in gait variability due to virtual reality that we are aware of is that of Hollman, *et al*.^[@CR56]^. However, Hollman, *et al*.^[@CR56]^ used an insufficient number of data points to reliably assess gait variability^[@CR55]^ and used a substantially different virtual reality setup to the current study. Finally, the effect sizes of the difference in step width variability with and without virtual reality and optic flow from Hollman, *et al*.^[@CR56]^ are much smaller than those found in the current study between Young and BVP All Gait groups at similar walking speeds (Cohen's d of 0.238--0.657 in Hollman, *et al*.^[@CR56]^ vs. 1.064--1.382 in the current study).

We also acknowledge that our division of participants into the BVP All Gait and BVP Part Gait groups is based on a rather simple criterion. Of the 12 participants in the BVP Part Gait group, the range of locomotor capacities within this group is likely broad. Reasons for lack of completion also varied across the participants, with some stopping due to lack of stability control (too much lateral deviation with a risk of stepping off the treadmill) and others unable to keep up with a faster belt speed. Nevertheless, we found significant group effects on gait variability, indicating the potential association between gait variability and overall locomotor capacity in BVP. Further research into gait parameters that can distinguish between patients with different functional limitations is encouraged to aid the development of accurate diagnostic functional testing protocols.

In conclusion, spatiotemporal gait parameters and their variability show speed-dependency in people with BVP and in healthy adults. In particular, step length variability at slower speeds and step width variability at faster speeds were the most distinguishing parameters between the healthy participants and people with BVP, and within groups with BVP who have different locomotor capacities. Gait variability in BVP was generally not correlated with the clinical tests of vestibular function. The current findings indicate that analysis of gait variability at multiple speeds has potential as an assessment tool for vestibular interventions.
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